Skip to main content
Avagenesis Corp. logo

Avagenesis Corp. — Investor Relations & Filings

Ticker · VVA TSXV Manufacturing
Filings indexed 101 across all filing types
Latest filing 2017-02-10 Regulatory Filings
Country CA Canada
Listing TSXV VVA

About Avagenesis Corp.

https://avagenesis.com/

Avagenesis Corp. is a biotechnology company specializing in the development and commercialization of automated bioprocessing and cell-isolation technologies. The company focuses on creating a standardized platform for the efficient isolation and enrichment of regenerative cells, primarily adipose stem cells, from human adipose tissue. This proprietary technology is designed to produce a highly potent regenerative biopharmaceutical product. Avagenesis targets premium medical markets, including applications in cosmetic and aesthetic medicine, burn management, and general regenerative therapy research. The company maintains quality standards, holding ISO 13485 and 9001 certifications for its cell isolation system.

Recent filings

Filing Released Lang Actions
Other securityholders documents - English.pdf
Regulatory Filings
2017-02-10 English
Notice (amended).pdf
Regulatory Filings
2017-02-10 English
Other securityholders documents - English.pdf
Regulatory Filings
2017-01-24 English
Notice.pdf
Regulatory Filings
2017-01-24 English
Material change report - English.pdf
Regulatory Filings
2017-01-11 English
News release - English.pdf
Regulatory Filings
2017-01-03 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.